                         SEQUENCE LISTING

<110>  YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW 
       UNIVERSITY OF JERUSALEM LTD.
 
<120>  PEPTIDES FOR THE TREATMENT OF MALIGNANT PROLIFERATIVE DISEASES

<130>  YISSUM/0114 PCT

<150>  US 62/113,452
<151>  2015-02-08

<160>  27    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa= Arg(Pbf)

<400>  1

Lys Gly His Tyr Ala Glu Xaa Val Gly 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X=Arg(Pbf)

<400>  2

Lys Gly His Tyr Xaa Ala Glu Val Gly 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X=Arg(Pbf)

<400>  3

Glu Ala Tyr His Gly Lys Xaa Gly Val 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X=Arg(NO2)

<400>  4

Lys Gly His Tyr Ala Glu Xaa Val Gly 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  5

Lys Gly His Tyr Ala Glu Arg Val Gly 
1               5                   


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is selected from Ala-Glu-Arg(Z), Ala-Arg(Z)-Glu and 
       Arg(Z)-Ala-Glu, Z is Pbf or NO2

<400>  6

Lys Gly His Tyr Xaa Val Gly 
1               5           


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys and alkyl-Lys

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X=Arg(Pbf)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol and Gly-ester

<400>  7

Xaa Gly His Tyr Ala Glu Xaa Val Xaa 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys and alkyl-Lys

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X=Arg(Pbf)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol and Gly-ester

<400>  8

Xaa Gly His Tyr Xaa Ala Glu Val Xaa 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys and alkyl-Lys

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X=Arg(NO2)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol and Gly-ester

<400>  9

Xaa Gly His Tyr Ala Glu Xaa Val Xaa 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys, alkyl-Lys and Lys modified with
       a permeability-enhancing or targeting moiety

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is Arg(Pbf) or Arg(NO2)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol, Gly-ester and Gly
       modified with a permeability-enhancing or targeting moiety

<400>  10

Xaa Gly His Tyr Ala Glu Xaa Val Xaa 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys, alkyl-Lys and Lys modified with
       a permeability-enhancing or targeting moiety

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is Arg(Pbf) or Arg(NO2)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol, Gly-ester and Gly
       modified with a permeability-enhancing or targeting moiety

<400>  11

Xaa Gly His Tyr Ala Xaa Glu Val Xaa 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys, alkyl-Lys and Lys modified with
       a permeability-enhancing or targeting moiety

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is Arg(Pbf) or Arg(NO2)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol, Gly-ester and Gly
       modified with a permeability-enhancing or targeting moiety

<400>  12

Xaa Gly His Tyr Xaa Ala Glu Val Xaa 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys, alkyl-Lys and Lys modified with
       a permeability-enhancing or targeting moiety

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is Arg(Pbf) or Arg(NO2)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol, Gly-ester and Gly
       modified with a permeability-enhancing or targeting moiety

<400>  13

Xaa Gly His Xaa Tyr Ala Glu Val Xaa 
1               5                   


<210>  14
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys, alkyl-Lys and Lys modified with
       a permeability-enhancing or targeting moiety

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is Arg(Pbf) or Arg(NO2)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol, Gly-ester and Gly
       modified with a permeability-enhancing or targeting moiety

<400>  14

Xaa Gly Xaa His Tyr Ala Glu Val Xaa 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys, alkyl-Lys and Lys modified with
       a permeability-enhancing or targeting moiety

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is Arg(Pbf) or Arg(NO2)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol, Gly-ester and Gly
       modified with a permeability-enhancing or targeting moiety

<400>  15

Xaa Xaa Gly His Tyr Ala Glu Val Xaa 
1               5                   


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys, alkyl-Lys and Lys modified with
       a permeability-enhancing or targeting moiety

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is Arg(Pbf) or Arg(NO2)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol, Gly-ester and Gly
       modified with a permeability-enhancing or targeting moiety

<400>  16

Xaa Gly His Tyr Ala Glu Val Xaa Xaa 
1               5                   


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is Arg(Pbf) or Arg(NO2)

<400>  17

Lys Gly His Tyr Ala Glu Xaa Val Gly 
1               5                   


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is Arg(Pbf) or Arg(NO2)

<400>  18

Lys Gly His Tyr Ala Xaa Glu Val Gly 
1               5                   


<210>  19
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is Arg(Pbf) or Arg(NO2)

<400>  19

Lys Gly His Tyr Xaa Ala Glu Val Gly 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is Arg(Pbf) or Arg(NO2)

<400>  20

Lys Gly His Xaa Tyr Ala Glu Val Gly 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is Arg(Pbf) or Arg(NO2)

<400>  21

Lys Gly Xaa His Tyr Ala Glu Val Gly 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is Arg(Pbf) or Arg(NO2)

<400>  22

Lys Xaa Gly His Tyr Ala Glu Val Gly 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is Arg(Pbf) or Arg(NO2)

<400>  23

Lys Gly His Tyr Ala Glu Val Xaa Gly 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is Arg(Pbf) or Arg(NO2)

<400>  24

Xaa Lys Gly His Tyr Ala Glu Val Gly 
1               5                   


<210>  25
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is Arg(Pbf) or Arg(NO2)

<400>  25

Lys Gly His Tyr Ala Glu Val Gly Xaa 
1               5                   


<210>  26
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Arg(Z), acyl-Arg(Z), alkyl-Arg(Z) and Arg(Z) 
       modified with a permeability enhancing or targeting moiety, Z is 
       Pbf or NO2

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Gly, Gly-amide, Gly-alcohol, Gly-ester and Gly
       modified with a permeability-enhancing or targeting moiety

<400>  26

Xaa Lys Gly His Tyr Ala Glu Val Xaa 
1               5                   


<210>  27
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is selected from Lys, acyl-Lys, alkyl-Lys and Lys modified with
       a permeability-enhancing or targeting moiety

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is selected from Arg(Z), Arg(Z)-amide, Arg(Z)-alcohol, 
       Arg(Z)-ester and Arg(Z) modified with a permeability-enhancing or
       targeting moiety, Z is Pbf or NO2

<400>  27

Lys Gly His Tyr Ala Glu Val Gly Xaa 
1               5                   


